ACT IRBESARTAN/HCT
ACT IRBESARTAN/HCT
Discontinued
DIN Number
02357399
Drug Class
Human
Market Date
Mar 21, 2011
Company
HC
actavis pharma company
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02357399
AIG Number0240086001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C09DA04 IRBESARTAN AND DIURETICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:32.08
Health Canada Classification
ACTIVE INGREDIENTS (2)
HYDROCHLOROTHIAZIDEActive
Strength: 12.5 MG
Monograph: HYDROCHLOROTHIAZIDE
IRBESARTANActive
Strength: 150 MG
Monograph: IRBESARTAN